Real-World Evidence Myths: 5 Things Pharma Teams Get Wrong About RWE, Claims Data and Study Design
Every year, pharma companies spend tens of millions of dollars on real-world evidence programmes that fail to deliver what was
Why Pharma Launches Fail: How Real-World Data Exposes the Market Sizing, Patient Journey and Payer Uptake Gaps Behind Failed Drug Launches
Here’s a number that should make any launch team uncomfortable: more than half of all pharma launches miss their commercial
Real-World Data Vendor Comparison: How to Evaluate Pharma Data Providers Without the Sales Pitch
Here’s a conversation I have more often than you’d think. A VP of Market Access — smart, experienced, absolutely knows
RWE Strategy for Lean Pharma Teams: How Small and Mid-Size Companies Can Leverage Real-World Evidence Without an Internal Function
You’re the Head of Market Access at a 200-person specialty biotech. Your lead asset is 18 months from a potential
Using Claims Data for Market Research in Pharma and MedTech
In pharma and MedTech, market research success hinges on answering questions that traditional surveys and clinical trial data simply can’t
Using Claims Data for Market Research in Pharma and MedTech Read Post »
AI-Driven Pharmaceutical Analytics and Forecasting for New Product Planning
Here’s what keeps pharma commercial leaders up at night: You’re staring at a $2.6 billion R&D investment for a first-in-class
AI-Driven Pharmaceutical Analytics and Forecasting for New Product Planning Read Post »
How Data Science Transforms Pharma: RWD, Claims Analytics & AI Modeling
The pharmaceutical industry is burning through approximately $2.6 billion per approved drug — a figure that’s doubled since 2000. Meanwhile,
How Data Science Transforms Pharma: RWD, Claims Analytics & AI Modeling Read Post »
Loss of Exclusivity in Pharma: Forecasting, Modeling and Market Impact Insights
Every pharma commercial leader knows the feeling. You’ve spent years building a blockbuster brand, navigating market access hurdles, defending your
Loss of Exclusivity in Pharma: Forecasting, Modeling and Market Impact Insights Read Post »